Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Dogs have a skin condition like human pseudopelade, causing hair loss that doesn't improve with treatment.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

A man with KID syndrome developed a rare cancer in a long-term skin infection.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.

The new device improves surgical accuracy by using a special dye and camera to see inside tissues.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

Isoniazid can rarely cause hair loss, which is reversible after stopping the drug.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Some patients temporarily lost hair after a certain bowel surgery, but it grew back without needing special treatment.

Recognizing the link between certain autoimmune disorders and neurological conditions can improve diagnosis and treatment.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Chronic bacterial infections of hair follicles can cause ongoing skin inflammation.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Early and accurate diagnosis is crucial for managing rare genetic disorders like this localized variant of junctional epidermolysis bullosa.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Children with celiac disease often have skin issues, best managed with a gluten-free diet and sometimes medication.

Microvascular damage and platelet issues persist in ulcerative colitis remission, helping assess disease states.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

A rare autoimmune disease caused the woman's scalp blisters and hair loss, successfully treated with medication.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

ILC1 cells contribute to hair loss in alopecia areata.